Company Filing History:
1 out of 517 
1 out of 4,455 
1 out of 1,361 
Years Active: 2025
Title: Brian Gaither Bates: Innovator in Antibody Drug Conjugates
Introduction
Brian Gaither Bates is a notable inventor based in Chelmsford, MA (US). He has made significant contributions to the field of targeted therapy, particularly through his work on CDCP1 antibodies and antibody drug conjugates. His innovative approach has the potential to impact cancer treatment and other medical applications.
Latest Patents
Brian Gaither Bates holds 1 patent related to his research on CUB domain-containing protein 1 (CDCP1)-targeted therapy. This patent provides materials and methods that could enhance therapeutic strategies in treating various diseases.
Career Highlights
Throughout his career, Bates has worked with prestigious organizations, including Beth Israel Deaconess Medical Center, Inc. and Pfizer Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Bates has had the opportunity to work alongside esteemed colleagues such as Lewis C. Cantley and Stephen P. Soltoff. These collaborations have further enriched his research and development efforts in the realm of antibody drug conjugates.
Conclusion
Brian Gaither Bates is a prominent figure in the field of targeted therapy, with a focus on CDCP1 antibodies. His innovative work and collaborations have the potential to lead to significant advancements in medical treatments.